G1 Therapeutics, Inc. financial data

Symbol
GTHX on Nasdaq
Industry
Pharmaceutical Preparations
Location
700 Park Offices Drive, Suite 200, Research Triangle Park, NC
State of incorporation
Delaware
Fiscal year end
December 31
Former names
G-Zero Therapeutics, Inc. (to 4/18/2013)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 322 % -28.4%
Quick Ratio 38.9 % -11%
Debt-to-equity 248 % +20.6%
Return On Equity -137 % +4.38%
Return On Assets -39.3 % +16.1%
Operating Margin -65.1 % +12.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.8M shares +1.96%
Common Stock, Shares, Outstanding 52.7M shares +1.91%
Entity Public Float 128M USD -39%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 52.5M shares +1.56%
Weighted Average Number of Shares Outstanding, Diluted 52.5M shares -14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 58.2M USD -34.7%
Research and Development Expense 29.2M USD -54.1%
Operating Income (Loss) -37.9M USD +43.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43M USD +42.6%
Income Tax Expense (Benefit) 1.81M USD -39.9%
Net Income (Loss) Attributable to Parent -44.8M USD +42.5%
Earnings Per Share, Basic -0.87 USD/shares +48.2%
Earnings Per Share, Diluted -0.84 USD/shares +50.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.1M USD -73%
Marketable Securities, Current 45.7M USD -5.51%
Accounts Receivable, after Allowance for Credit Loss, Current 13.3M USD +1.05%
Inventory, Net 13.4M USD -14.2%
Assets, Current 92.9M USD -33.8%
Property, Plant and Equipment, Net 1.24M USD -28.5%
Operating Lease, Right-of-Use Asset 4.35M USD -20.2%
Assets 98.7M USD -33.3%
Accounts Payable, Current 5.16M USD -10.5%
Employee-related Liabilities, Current 1.97M USD -28.2%
Accrued Liabilities, Current 17.1M USD -30.8%
Liabilities, Current 37.5M USD +10.6%
Operating Lease, Liability, Noncurrent 3.65M USD -27%
Other Liabilities, Noncurrent 41K USD
Liabilities 74.1M USD -18%
Retained Earnings (Accumulated Deficit) -796M USD -5.96%
Stockholders' Equity Attributable to Parent 24.6M USD -57.3%
Liabilities and Equity 98.7M USD -33.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.9M USD +69.4%
Net Cash Provided by (Used in) Financing Activities -8.72M USD -3976%
Net Cash Provided by (Used in) Investing Activities 5.29M USD +81.8%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 52.7M shares +1.91%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -12.3M USD +53.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.82M USD -27.4%
Deferred Tax Assets, Valuation Allowance 184M USD +5.68%
Deferred Tax Assets, Gross 185M USD +5.45%
Operating Lease, Liability 5.62M USD -16.8%
Depreciation 881K USD +63.8%
Lessee, Operating Lease, Liability, to be Paid 6.53M USD -20%
Operating Lease, Liability, Current 1.28M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.73M USD +2.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.68M USD +2.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 918K USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.77M USD +2.78%
Deferred Tax Assets, Operating Loss Carryforwards 121M USD +2.32%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.36M USD -23.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 120K USD -9.09%
Share-based Payment Arrangement, Expense 11.5M USD -31.7%